1-deoxynojirimycin has been researched along with Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ivaturi, V; Johnson, FK; Leonowens, C; Schmith, V; Wu, YS; Zhou, J | 1 |
| Dingemanse, J; Guérard, N; Zwingelstein, C | 1 |
| Kaminsky, P; Lidove, O | 1 |
1 review(s) available for 1-deoxynojirimycin and Kidney Failure
| Article | Year |
|---|---|
[Current therapeutic strategies in lysosomal disorders].
Topics: 1-Deoxynojirimycin; Codon, Nonsense; Codon, Terminator; Cystine Depleting Agents; Enzyme Inhibitors; Enzyme Replacement Therapy; Gene Expression Regulation; Hematopoietic Stem Cell Transplantation; Humans; Imino Pyranoses; Lysosomal Storage Diseases; Mutant Proteins; Renal Insufficiency | 2014 |
1 trial(s) available for 1-deoxynojirimycin and Kidney Failure
| Article | Year |
|---|---|
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Pharmacokinetics, Tolerability, and Safety in Subjects With Mild, Moderate, and Severe Renal Function Impairment.
Topics: 1-Deoxynojirimycin; Adult; Aged; Animals; Area Under Curve; Dogs; Female; Half-Life; Humans; Kidney; Male; Middle Aged; Prospective Studies; Rats; Renal Insufficiency; Young Adult | 2017 |
1 other study(ies) available for 1-deoxynojirimycin and Kidney Failure
| Article | Year |
|---|---|
Population Pharmacokinetics of Oral Migalastat in Adolescents and Adults With and Without Renal Impairment.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Child; Fabry Disease; Glomerular Filtration Rate; Humans; Renal Insufficiency | 2022 |